A randomized, placebo-controlled, phase 3 study of the safety and efficacy of solriamfetol (JZP-110) for the treatment of excessive sleepiness in patients with narcolepsy

Authors
Category Primary study
JournalSleep Medicine
Year 2017
This article has no abstract
Epistemonikos ID: 6a4dcfc86d815f48bee1d7429b2d84a3280b9c75
First added on: Feb 08, 2025